Use of electronic monitoring in clinical nursing research

Clinical Nursing Research

Volumn 17, Issue 2, 2008, Pages 89-97

  Ailinger, Rita L ^a   Black, Patricia L ^b   Lima Garcia, Natalie ^c  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGE MASON UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Adherence; Electronic monitoring; Medication event monitoring system; MEMS

Indexed keywords

ISONIAZID; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CLINICAL NURSING RESEARCH; COMPUTER ASSISTED DRUG THERAPY; DRUG MONITORING; DRUG THERAPY; ELECTRONICS; EPIDEMIOLOGY; ETHICS; FEMALE; HUMAN; INFORMATION PROCESSING; MALE; METHODOLOGY; NURSE ATTITUDE; NURSING; NURSING ASSESSMENT; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; SINGLE BLIND PROCEDURE; STATISTICS; TUBERCULOSIS;

ADULT; ANTITUBERCULAR AGENTS; BIAS (EPIDEMIOLOGY); CLINICAL NURSING RESEARCH; DATA COLLECTION; DRUG MONITORING; DRUG THERAPY; DRUG THERAPY, COMPUTER-ASSISTED; ELECTRONICS; FEMALE; HUMANS; ISONIAZID; MALE; NURSE'S ROLE; NURSING ASSESSMENT; PATIENT COMPLIANCE; RESEARCH DESIGN; SINGLE-BLIND METHOD; TUBERCULOSIS;

EID: 41549165702     PISSN: 10547738     EISSN: 15523799     Source Type: Journal    
DOI: 10.1177/1054773808316941     Document Type: Article

References (19)

1. Ailinger, R.L., Moore, J.B., Nguyen, N., & Lasus, H. (2006). Adherence to latent tuberculosis infection therapy among Latino immigrants. Public Health Nursing 23 (4). 307-313.
2. Blumberg, E.J., Hovell, M.F., Kelley, N.J., Vera, A.Y., Sipan, C.L., & Berg, J.P. (2005). Self-report INH adherence measures were reliable and valid in Latino adolescents with latent tuberculosis infection. Journal of Clinical Epidemiology, 58 (6). 645-648.
3. Bova, C.A., Fennie, K.P., Knafl, G.J., Dieckhaus, K.D., Watrous, E., & Williams, A.B. (2005). Use of electronic monitoring devices to measure antiretroviral adherence: practical considerations. AIDS & Behavior, 9 (1). 103-110.
4. Cain, K.P., Haley, C.A., Armstrong, L.R., Garman, K.N., Wells, C.C., Lademarco, M.F., et al. (2007). Tuberculosis among foreign-born persons in the United States achieving tuberculosis elimination. American Journal of Respiratory & Critical Care Medicine, 175, 75-79.
5. Centers for Disease Control and Prevention. (2005). Guide for primary health care providers: Targeted tuberculin testing and treatment of latent tuberculosis infection 2005. Retrieved May 22, 2006, from http://www.cdc.gov/tb/ pubs/LTBI/treatment.htm
6. Claxton, A.J., Cramer, J., & Pierce, C. (2001). A systematic review of the associations between dose regimens and medication compliance. Clinical Therapeutics, 23 (8). 1296-1310.
7. de Bruin, M., Hospers, H.J., van den Borne, H.W., Kok, G., & Prins, J.M. (2005). Theory-and evidence-based intervention to improve adherence to antiretroviral therapy among HIV-infected patients in the Netherlands: A pilot study. AIDS Patient Care and STDs, 19 (6). 384-394.
8. DiMatteo, M.R., Giordani, P.J., Lepper, H.S., & Croghan, T.W. (2002). Patient adherence and medical treatment outcomes: A meta-analysis. Medical Care, 40 (9). 794-811.
9. Eidlitz-Markus, T., Zeharia, A., Baum, G., Mimouni, M., & Amir, J. (2003). Use of the urine color test to monitor compliance with isoniazid treatment of latent tuberculosis infection. Chest, 123 (3). 736-739.
10. Feinn, R., Tennen, H., Cramer, J., & Kranzler, H.R. (2003). Measurement and prediction of medication compliance in problem drinkers. Alcoholism: Clinical & Experimental Research, 27 (8). 1286-1292.
11. Hamilton, G.A. (2003). Measuring adherence in a hypertension clinical trial. European Journal of Cardiovascular Nursing, 2 (3). 219-228.
12. Hinkin, C.H., Castellon, S.A., Durvasula, R.S., Hardy, D.J., Lam, M.N., Mason, K.I., et al. (2002). Medication adherence among HIV+ adults: Effects of cognitive dysfunction and regimen complexity. Neurology, 59 (12). 1944-1950.
13. Holzemer, W.L., Bakken, S., Portillo, C.J., Grimes, R., Welch, J., Wantland, D., et al. (2006). Testing a nurse-tailored HIV medication adherence intervention. Nursing Research, 55 (3). 189-197.
14. Horsburgh, C.R., Jr. (2004). Priorities for the treatment of latent tuberculosis infection in the United States. New England Journal of Medicine, 350, 2060-2067.
15. Menzies, D., Dion, M.J., Francis, D., Parisien, I., Rocher, I., Mannix, S., et al. (2005). In closely monitored patients, adherence in the first month predicts completion of therapy for latent tuberculosis infection. International Journal of Tuberculosis and Lung Disease, 9 (12). 1343-1348.
16. Perry, S., Hovell, M.F., Blumberg, E., Berg, J., Vera, A., Sipan, C., et al. (2002). Urine testing to monitor adherence to TB preventive therapy. Journal of Clinical Epidemiology, 55 (3). 235-238.
17. Samet, J.H., Sullivan, L.M., Traphagen, E.T., & Ickovics, J.R. (2001). Measuring adherence among HIV-infected persons: Is MEMS consummate technology ? AIDS and Behavior, 5 (1). 21-30.
18. White, M.C., Gournis, E., Kawamura, M., Menendez, E., & Tulsky, J.P. (2003). Effect of directly observed preventive therapy for latent tuberculosis infection in San Francisco. International Journal of Tuberculosis and Lung Disease, 7 (1). 30-35.
19. Williams, A.B., Fennie, K.P., Bova, C.A., Burgess, J.D., Danvers, K.A., & Dieckhaus, K.D. (2006). Home visits to improve adherence to highly active antiretroviral therapy: A randomized controlled trial. Journal of Acquired Immune Deficiency Syndromes, 42 (3). 314-321.